Niels van Namen - executive vice president, Healthcare at CEVA Logistics and Stephen Barksfield - global BD program director, Healthcare at CEVA Logistics look at how logistics is affecting the future pipeline of pharma.
The pace of change across the pharmaceutical industry is growing at an ever-increasing rate. Over the last decade, demand from global markets has challenged the industry to act more quickly to produce much needed innovative treatments. With the aid of technology over the past decade, the industry has fundamentally changed the way it operates.
Today, changing molecular and technology shifts are driving new research methods. Small molecule drugs, many of which date back to the 1800s like aspirin that is composed of just 21 atoms, now compare with a growth hormone drug of around 3,000 atoms or a large biologic drug of 25,000 atoms. Accordingly, the complexities of production and distribution have grown in recent years.